| Dr Mark Anthony Johnson, MD | |
|
811 Ridgewood Avenue, Venice, FL 34285 | |
| (941) 480-0600 | |
| (941) 485-8090 |
| Full Name | Dr Mark Anthony Johnson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 36 Years |
| Location | 811 Ridgewood Avenue, Venice, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205803418 | NPI | - | NPPES |
| 379740600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME64457 (Florida) | Primary |
| Entity Name | The Eye Associates Of Manatee, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366483851 PECOS PAC ID: 4688664535 Enrollment ID: O20040513001080 |
News Archive
Three Case Western Reserve University faculty members have received funding to further develop emerging technologies aimed at malaria, cystic fibrosis, and sickle cell anemia.
For years biomedical researchers have known that high density lipoproteins, commonly called HDLs or "good cholesterol," are responsible for protecting humans from certain parasites, but couldn't explain how.
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania.
Muscular dystrophy is caused by the largest human gene, a complex chemical leviathan that has confounded scientists for decades. Research conducted at the University of Missouri and described this month in the Proceedings of the National Academy of Sciences has identified significant sections of the gene that could provide hope to young patients and families.
BloodCenter of Wisconsin (BCW) today announced that the National Institutes of Health (NIH) has awarded a $1.4 million Small Business Technology Transfer grant to fund continued research into the deployment of Radio Frequency Identification (RFID) technology to enhance safety and reduce hospital costs related to the collection, manufacture and transfusion of blood products. The NIH grant allows the first-ever research into the potential clinical and financial benefits of RFID technology for automatic identification, tracking, and status monitoring of blood and blood products across the entire transfusion medicine supply chain.
› Verified 9 days ago
| Entity Name | Mark Johnson Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730152752 PECOS PAC ID: 2668432774 Enrollment ID: O20041013000824 |
News Archive
Three Case Western Reserve University faculty members have received funding to further develop emerging technologies aimed at malaria, cystic fibrosis, and sickle cell anemia.
For years biomedical researchers have known that high density lipoproteins, commonly called HDLs or "good cholesterol," are responsible for protecting humans from certain parasites, but couldn't explain how.
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania.
Muscular dystrophy is caused by the largest human gene, a complex chemical leviathan that has confounded scientists for decades. Research conducted at the University of Missouri and described this month in the Proceedings of the National Academy of Sciences has identified significant sections of the gene that could provide hope to young patients and families.
BloodCenter of Wisconsin (BCW) today announced that the National Institutes of Health (NIH) has awarded a $1.4 million Small Business Technology Transfer grant to fund continued research into the deployment of Radio Frequency Identification (RFID) technology to enhance safety and reduce hospital costs related to the collection, manufacture and transfusion of blood products. The NIH grant allows the first-ever research into the potential clinical and financial benefits of RFID technology for automatic identification, tracking, and status monitoring of blood and blood products across the entire transfusion medicine supply chain.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Anthony Johnson, MD 1824 Island Way, Osprey, FL 34229 Ph: (941) 918-9522 | Dr Mark Anthony Johnson, MD 811 Ridgewood Avenue, Venice, FL 34285 Ph: (941) 480-0600 |
News Archive
Three Case Western Reserve University faculty members have received funding to further develop emerging technologies aimed at malaria, cystic fibrosis, and sickle cell anemia.
For years biomedical researchers have known that high density lipoproteins, commonly called HDLs or "good cholesterol," are responsible for protecting humans from certain parasites, but couldn't explain how.
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania.
Muscular dystrophy is caused by the largest human gene, a complex chemical leviathan that has confounded scientists for decades. Research conducted at the University of Missouri and described this month in the Proceedings of the National Academy of Sciences has identified significant sections of the gene that could provide hope to young patients and families.
BloodCenter of Wisconsin (BCW) today announced that the National Institutes of Health (NIH) has awarded a $1.4 million Small Business Technology Transfer grant to fund continued research into the deployment of Radio Frequency Identification (RFID) technology to enhance safety and reduce hospital costs related to the collection, manufacture and transfusion of blood products. The NIH grant allows the first-ever research into the potential clinical and financial benefits of RFID technology for automatic identification, tracking, and status monitoring of blood and blood products across the entire transfusion medicine supply chain.
› Verified 9 days ago
P Dee G Stephenson, M.D., P.A. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Palermo Pl, Venice, FL 34285 Phone: 941-485-1121 Fax: 941-486-0571 | |
Dr. Jesse Thomas Mccann, MD PHD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1360 E Venice Ave, Venice, FL 34285 Phone: 941-488-2020 Fax: 941-484-2200 | |
Dr. Priya Mary Mathews, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1360 E Venice Ave, Venice, FL 34285 Phone: 941-488-2020 | |
Donald Alvin Mceachern, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1511 Tamiami Trl S, Suite 201, Venice, FL 34285 Phone: 941-497-2138 Fax: 941-493-2598 | |
John P Fezza, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1370 E Venice Ave Ste 205, Venice, FL 34285 Phone: 941-488-2020 | |
Dr. William John Mestrezat, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1360 E Venice Ave, Venice, FL 34285 Phone: 941-488-2020 Fax: 941-484-2200 |